Cargando…
FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease. Although numerous reports have demonstrated a correlation between epithelial-mesenchymal transition (EMT) and renal fibrosis, how these processes lead to tubular dysfunction remains unclear. Here, we show that FOXO3a prot...
Autores principales: | Wang, Xiaowei, Ji, Tingting, Li, Xiaoying, Qu, Xiaolei, Bai, Shoujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172321/ https://www.ncbi.nlm.nih.gov/pubmed/34122724 http://dx.doi.org/10.1155/2021/5565761 |
Ejemplares similares
-
hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
por: Bai, Shoujun, et al.
Publicado: (2021) -
Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3/NF-κB/MMP-2 axis
por: Bai, Shoujun, et al.
Publicado: (2020) -
SIRT1 rs10823108 and FOXO1 rs17446614 responsible for genetic susceptibility to diabetic nephropathy
por: Zhao, Yanyan, et al.
Publicado: (2017) -
EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer
por: Mahmud, Zimam, et al.
Publicado: (2019) -
Phosphorylation and acetylation modifications of FOXO3a: Independently or synergistically?
por: Wang, Xianwang, et al.
Publicado: (2017)